Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

AcelRx Pharmaceuticals

0.8600
0.0000
Volume:- -
Turnover:201.45K
Market Cap:14.58M
PE:-0.48
High:0.8600
Open:0.8600
Low:0.8600
Close:0.8600
52wk High:2.78
52wk Low:0.4250
Shares:16.95M
Float Shares:12.03M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7875
EPS(LYR):5.73
ROE:-51.12%
ROA:-32.21%
PB:0.80
PE(LYR):0.15

Loading ...

OverviewCompanyNewsFilings

BRIEF-Acelrx Announces Rebranding With Name Change To Talphera Inc

Reuters
·
Jan 09, 2024

BRIEF-Acelrx Pharmaceuticals Announces Publication Of Study Evaluating Anticoagulation Practices For Continuous Renal Replacement Therapy In The United States

Reuters
·
Dec 12, 2023

AcelRx Pharmaceuticals Q3 2023 Gaap EPS $(0.08) Beats $(0.28) Estimate, Sales $117.00K Miss $130.00K Estimate

Benzinga
·
Nov 09, 2023

BRIEF-AcelRx Pharmaceuticals Q3 net income from cont ops USD -1.418 million

Reuters
·
Nov 09, 2023

BRIEF-Acelrx Pharmaceuticals - On Oct 18, Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement

Reuters
·
Oct 21, 2023

BRIEF-Acelrx Receives Ide Approval For Niyad And Advances To A Single Registration Study

Reuters
·
Oct 03, 2023

BUZZ-AcelRx slides after FDA refuses 'EUA' tag to blood thinner device

Reuters
·
Sep 26, 2023

BRIEF-Acelrx Pharmaceuticals Inc - FDA Determined That Review Of Niyad Eua Is Not A Priority And Has Therefore Declined To Issue An Eua For Niyad

Reuters
·
Sep 23, 2023
More

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Symbol Change
Jan 10, 2024 TLPH
Financial Report Announcement
Nov 08, 2023 Post Market
Financial Report Announcement
Aug 10, 2023 Post Market
Financial Report Announcement
May 10, 2023 Post Market
Financial Report Announcement
Mar 30, 2023 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.48
Current
-2.24
Sector Average
74.46%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.48
Maximum
1.03
+1 STD
-0.34
Minimum
-5.06
-1 STD
-4.13
Average
-2.24

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.